Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2020 1
2021 2
2022 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia.
Mwaba J, Chisenga CC, Xiao S, Ng'ombe H, Banda E, Shea P, Mabula-Bwalya C, Mwila-Kazimbaya K, Laban NM, Alabi P, Chirwa-Chobe M, Simuyandi M, Harris J, Iyer AS, Bosomprah S, Scalzo P, Murt KN, Ram M, Kwenda G, Ali M, Sack DA, Chilengi R, Debes AK. Mwaba J, et al. Among authors: laban nm. Vaccine. 2021 Jul 22;39(32):4516-4523. doi: 10.1016/j.vaccine.2021.06.034. Epub 2021 Jul 1. Vaccine. 2021. PMID: 34217572 Clinical Trial.
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial.
Laban NM, Bosomprah S, Simuyandi M, Chibuye M, Chauwa A, Chirwa-Chobe M, Sukwa N, Chipeta C, Velu R, Njekwa K, Mubanga C, Mwape I, Goodier MR, Chilengi R. Laban NM, et al. Vaccines (Basel). 2023 Feb 3;11(2):346. doi: 10.3390/vaccines11020346. Vaccines (Basel). 2023. PMID: 36851224 Free PMC article.
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia.
Chauwa A, Bosomprah S, Laban NM, Phiri B, Chibuye M, Chilyabanyama ON, Munsaka S, Simuyandi M, Mwape I, Mubanga C, Chobe MC, Chisenga C, Chilengi R. Chauwa A, et al. Among authors: laban nm. Vaccines (Basel). 2023 Jul 31;11(8):1303. doi: 10.3390/vaccines11081303. Vaccines (Basel). 2023. PMID: 37631871 Free PMC article.
Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.
Mwila-Kazimbaya K, Bosomprah S, Chilyabanyama ON, Chisenga CC, Chibuye M, Laban NM, Simuyandi M, Huffer B Jr, Iturriza-Gomara M, Choy RKM, Chilengi R. Mwila-Kazimbaya K, et al. Among authors: laban nm. PLoS One. 2023 Nov 17;18(11):e0293101. doi: 10.1371/journal.pone.0293101. eCollection 2023. PLoS One. 2023. PMID: 37976323 Free PMC article.
In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.
Kazimbaya KM, Chisenga CC, Simuyandi M, Phiri CM, Laban NM, Bosomprah S, Permar SR, Munsaka S, Chilengi R. Kazimbaya KM, et al. Among authors: laban nm. PLoS One. 2020 Nov 10;15(11):e0240714. doi: 10.1371/journal.pone.0240714. eCollection 2020. PLoS One. 2020. PMID: 33170860 Free PMC article.
Characterization of Rotavirus Strains Responsible for Breakthrough Diarrheal Diseases among Zambian Children Using Whole Genome Sequencing.
Mwape I, Laban NM, Chibesa K, Moono A, Silwamba S, Malisheni MM, Chisenga C, Chauwa A, Simusika P, Phiri M, Simuyandi M, Chilengi R, De Beer C, Ojok D. Mwape I, et al. Among authors: laban nm. Vaccines (Basel). 2023 Nov 26;11(12):1759. doi: 10.3390/vaccines11121759. Vaccines (Basel). 2023. PMID: 38140164 Free PMC article.
11 results